CLOs on the Move

Amplivox

www.amplivox.com

 
Amplivox is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.amplivox.com
  • 5000 Cheshire Pkwy N
    Minneapolis, MN USA 55446
  • Phone: 888.510.0766

Executives

Name Title Contact Details

Similar Companies

Palmetto Health

Palmetto Health is South Carolina's largest and most comprehensive healthcare resource. In our progressive environment, the latest technology and treatment protocols go hand-in-hand with quality patient care.

Providence Medical Technology

Providence Medical Technology is a privately held medical device company developing innovative solutions addressing the $1 billion worldwide cervical spine market. We are commercializing the DTRAX platform of differentiated cervical implants and instruments to treat cervical degenerative disease through indirect decompression and fusion.

Acuitec

Acuitec is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Birmingham, AL. To find more information about Acuitec, please visit www.acuitec.com

AIDS Commnty Rsrch Consortium

AIDS Commnty Rsrch Consortium is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Massive Bio

Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.